Article

ForbesForbes on 2020-06-29 20:55

The Other Shoe Drops: Gilead’s Outrageous Pricing Of Remdesivir

This is an unreasonable price for a drug that has demonstrated little to no ability to save lives or lower viral loads in patients.

Related news